Barbara A. Pelak

1.2k total citations
28 papers, 939 citations indexed

About

Barbara A. Pelak is a scholar working on Pharmacology, Molecular Medicine and Molecular Biology. According to data from OpenAlex, Barbara A. Pelak has authored 28 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 13 papers in Molecular Medicine and 8 papers in Molecular Biology. Recurrent topics in Barbara A. Pelak's work include Antibiotics Pharmacokinetics and Efficacy (20 papers), Antibiotic Resistance in Bacteria (13 papers) and Drug Transport and Resistance Mechanisms (4 papers). Barbara A. Pelak is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (20 papers), Antibiotic Resistance in Bacteria (13 papers) and Drug Transport and Resistance Mechanisms (4 papers). Barbara A. Pelak collaborates with scholars based in United States and Japan. Barbara A. Pelak's co-authors include H Kropp, Hiroshi Ōnishi, Arthur A. Patchett, Sheryl A. Hyland, Lynn L. Silver, Christian R.H. Raetz, Susan Galloway, Meng‐Hsin Chen, Matt S. Anderson and Frederick M. Kahan and has published in prestigious journals such as Science, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Barbara A. Pelak

28 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara A. Pelak United States 14 329 302 241 205 180 28 939
Paul Actor United States 17 277 0.8× 320 1.1× 177 0.7× 231 1.1× 167 0.9× 72 988
J N Hobbs United States 17 539 1.6× 224 0.7× 158 0.7× 340 1.7× 93 0.5× 18 980
Brian J. Morrow United States 19 443 1.3× 226 0.7× 362 1.5× 285 1.4× 203 1.1× 33 1.2k
J. Allan Waitz United States 21 449 1.4× 632 2.1× 428 1.8× 209 1.0× 194 1.1× 56 1.4k
Raúl Goldschmidt United States 18 537 1.6× 254 0.8× 225 0.9× 246 1.2× 304 1.7× 35 1.2k
Patrick J. Cassidy United States 6 312 0.9× 229 0.8× 325 1.3× 111 0.5× 205 1.1× 8 786
Jin‐Hwan Kwak South Korea 18 438 1.3× 196 0.6× 158 0.7× 176 0.9× 114 0.6× 47 984
M Berti Italy 17 493 1.5× 520 1.7× 136 0.6× 329 1.6× 153 0.8× 43 1.1k
Magdalena Zalacaín United States 23 905 2.8× 322 1.1× 304 1.3× 181 0.9× 220 1.2× 40 1.4k
Sergio Lociuro Switzerland 18 547 1.7× 238 0.8× 356 1.5× 225 1.1× 133 0.7× 37 1.3k

Countries citing papers authored by Barbara A. Pelak

Since Specialization
Citations

This map shows the geographic impact of Barbara A. Pelak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara A. Pelak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara A. Pelak more than expected).

Fields of papers citing papers by Barbara A. Pelak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara A. Pelak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara A. Pelak. The network helps show where Barbara A. Pelak may publish in the future.

Co-authorship network of co-authors of Barbara A. Pelak

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara A. Pelak. A scholar is included among the top collaborators of Barbara A. Pelak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara A. Pelak. Barbara A. Pelak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pelak, Barbara A., et al.. (2002). Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections. Clinical Microbiology and Infection. 8(11). 753–757. 15 indexed citations
2.
Pelak, Barbara A., Gail L. Woods, Hedy Teppler, et al.. (2002). ComparativeIn-VitroActivities of Ertapenem against Aerobic Bacterial Pathogens Isolated from Patients with Complicated Intra-abdominal Infections. Journal of Chemotherapy. 14(3). 227–233. 18 indexed citations
3.
Pelak, Barbara A.. (2002). Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection. Journal of Antimicrobial Chemotherapy. 50(5). 735–741. 18 indexed citations
4.
Pelak, Barbara A., Ken Bartizal, Gail L. Woods, Richard Gesser, & Mary Motyl. (2002). Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections. Diagnostic Microbiology and Infectious Disease. 43(2). 129–133. 15 indexed citations
5.
Gill, Charles, Jesse J. Jackson, Barbara A. Pelak, et al.. (1998). In Vivo Activity and Pharmacokinetic Evaluation of a Novel Long-Acting Carbapenem Antibiotic, MK-826 (L-749,345). Antimicrobial Agents and Chemotherapy. 42(8). 1996–2001. 57 indexed citations
6.
Alexander, Jose, et al.. (1991). (Acyloxy)alkyl carbamate prodrugs of norfloxacin. Journal of Medicinal Chemistry. 34(1). 78–81. 39 indexed citations
7.
8.
Pelak, Barbara A., George K. Abruzzo, Robert A. Fromtling, et al.. (1989). L-658,310, a new injectable cephalosporin. III. Experimental chemotherapeutics and pharmacokinetics in laboratory animals.. The Journal of Antibiotics. 42(5). 815–822. 3 indexed citations
9.
Onishi, Janet C., George K. Abruzzo, Robert A. Fromtling, et al.. (1988). Mode of Action of β‐Lactone 1233A in Candida albicans. Annals of the New York Academy of Sciences. 544(1). 230–230. 1 indexed citations
10.
Pelak, Barbara A., et al.. (1988). L-656,575 (OCP-9-176): A novel oxacephem pharmacokinetics and experimental chemotherapy.. The Journal of Antibiotics. 41(8). 1137–1141. 4 indexed citations
11.
Onishi, Janet C., George K. Abruzzo, Robert A. Fromtling, et al.. (1988). Mode Of Action of L‐660,631 in Candida albicans. Annals of the New York Academy of Sciences. 544(1). 229–229. 2 indexed citations
12.
Zimmerman, S. B., Cheryl D. Schwartz, Richard L. Monaghan, et al.. (1987). Difficidin and oxydifficidin: Novel broad spectrum antibacterial antibiotics produced by Bacillus subtilis. I.Production, taxonomy and antibacterial activity.. The Journal of Antibiotics. 40(12). 1677–1681. 79 indexed citations
13.
Wilson, Kenneth E., Robert E. Schwartz, H Joshua, et al.. (1987). Difficidin and oxydifficidin: Novel broad spectrum antibacterial antibiotics produced by Bacillus subtilis. II. Isolation and physico-chemical characterization.. The Journal of Antibiotics. 40(12). 1682–1691. 49 indexed citations
14.
Pelak, Barbara A., et al.. (1987). Quaternary heterocyclylamino .BETA.-lactams. VI In vitro and in vivo antibacterial properties of L-642,946 and L-652,813, a long acting cephem.. The Journal of Antibiotics. 40(3). 354–362. 2 indexed citations
15.
Fromtling, Robert A., et al.. (1986). Norfloxacin versus trimethoprim-sulphamethoxazole: efficacy in a model of ascending urinary tract infection in normal and streptozotocin-induced diabetic mice. Journal of Antimicrobial Chemotherapy. 16(6). 735–741. 1 indexed citations
16.
Pelak, Barbara A., et al.. (1984). Pharmacokinetic Studies of Norfloxacin in Laboratory Animals. Chemotherapy. 30(5). 288–296. 22 indexed citations
17.
Koupal, Lawrence R., Barbara A. Pelak, Patrick J. Cassidy, & H. H. Gadebusch. (1983). Quaternary heterocyclylamino .BETA.-lactams. III. The mode of action of L-640,876 and the effect of NaCl on membrane permeability and binding.. The Journal of Antibiotics. 36(1). 54–63. 2 indexed citations
18.
Birnbaum, Jerome, E. O. Stapley, A. Kathrine Miller, et al.. (1979). Development of the semisynthetic cephamycin, cefoxitin, as a clinical candidate. Infection. 7(S1). S13–S20. 4 indexed citations
19.
Miller, A. Kathrine, et al.. (1977). The enhancement of .BETA.-lactam antibiotic therapy by novobiocin.. The Journal of Antibiotics. 30(11). 983–986. 1 indexed citations
20.
Miller, A. Kathrine, et al.. (1972). Cephamycins, a New Family of β-Lactam Antibiotics. III. In Vitro Studies. Antimicrobial Agents and Chemotherapy. 2(4). 281–286. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Actor Breakdown of academic impact, for papers by J N Hobbs Breakdown of academic impact, for papers by Brian J. Morrow Breakdown of academic impact, for papers by J. Allan Waitz Breakdown of academic impact, for papers by Raúl Goldschmidt Breakdown of academic impact, for papers by Patrick J. Cassidy Breakdown of academic impact, for papers by Jin‐Hwan Kwak Breakdown of academic impact, for papers by M Berti Breakdown of academic impact, for papers by Magdalena Zalacaín Breakdown of academic impact, for papers by Sergio Lociuro
Rankless by CCL
2026